title: Rapid growth of Merkel cell carcinoma during etanercept treatment of psoriatic arthritis: cause or coincidence?
authors.forename: Vincenzo
authors.initials: V
authors.lastname: de Giorgi
authors.forename: Silvia
authors.initials: S
authors.lastname: Benemei
authors.forename: Marta
authors.initials: M
authors.lastname: Grazzini
authors.forename: Torello
authors.initials: T
authors.lastname: Lotti
authors.forename: Pierangelo
authors.initials: P
authors.lastname: Geppetti
mesh_terms: D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D015266:Carcinoma, Merkel Cell / Q000209:etiology* / Q000556:secondary / Q000601:surgery; D004334:Drug Administration Schedule; D000068800:Etanercept; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage; D012307:Risk Factors; D012878:Skin Neoplasms / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D013997:Time Factors
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept